The Pennant Group (NASDAQ:PNTG) Coverage Initiated at Jefferies Financial Group

Investment analysts at Jefferies Financial Group began coverage on shares of The Pennant Group (NASDAQ:PNTGGet Free Report) in a report released on Friday,Benzinga reports. The firm set a “buy” rating and a $30.00 price target on the stock. Jefferies Financial Group’s target price indicates a potential upside of 22.55% from the company’s current price.

PNTG has been the topic of several other research reports. Stephens reissued an “overweight” rating and set a $40.00 price target on shares of The Pennant Group in a research report on Thursday, October 9th. Truist Financial lowered their price target on shares of The Pennant Group from $32.00 to $28.00 and set a “hold” rating on the stock in a research report on Wednesday, July 16th. Wells Fargo & Company lowered their price target on shares of The Pennant Group from $31.00 to $29.00 and set an “equal weight” rating on the stock in a research report on Thursday, August 14th. Wall Street Zen cut shares of The Pennant Group from a “buy” rating to a “hold” rating in a research report on Friday, September 26th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of The Pennant Group in a research report on Tuesday, October 14th. Three research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $32.80.

Read Our Latest Report on The Pennant Group

The Pennant Group Trading Down 2.0%

Shares of PNTG opened at $24.48 on Friday. The Pennant Group has a 52-week low of $21.18 and a 52-week high of $34.82. The company has a quick ratio of 1.21, a current ratio of 1.21 and a debt-to-equity ratio of 0.11. The firm’s fifty day moving average is $24.70 and its two-hundred day moving average is $25.84. The stock has a market cap of $846.03 million, a PE ratio of 31.38, a price-to-earnings-growth ratio of 2.11 and a beta of 1.35.

Institutional Trading of The Pennant Group

Several institutional investors and hedge funds have recently bought and sold shares of PNTG. Rice Hall James & Associates LLC raised its holdings in The Pennant Group by 43.8% in the 1st quarter. Rice Hall James & Associates LLC now owns 240,649 shares of the company’s stock valued at $6,052,000 after buying an additional 73,300 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH purchased a new stake in The Pennant Group in the 1st quarter valued at about $428,000. Van Berkom & Associates Inc. raised its holdings in The Pennant Group by 29.6% in the 1st quarter. Van Berkom & Associates Inc. now owns 2,849,562 shares of the company’s stock valued at $71,666,000 after buying an additional 651,346 shares during the period. Mackenzie Financial Corp raised its holdings in The Pennant Group by 25.2% in the 1st quarter. Mackenzie Financial Corp now owns 22,446 shares of the company’s stock valued at $565,000 after buying an additional 4,522 shares during the period. Finally, Premier Fund Managers Ltd purchased a new stake in The Pennant Group in the 1st quarter valued at about $535,000. 85.88% of the stock is currently owned by hedge funds and other institutional investors.

About The Pennant Group

(Get Free Report)

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.

Read More

Analyst Recommendations for The Pennant Group (NASDAQ:PNTG)

Receive News & Ratings for The Pennant Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Pennant Group and related companies with MarketBeat.com's FREE daily email newsletter.